Next Generation Sequencing (NGS) is the most advanced platform for DNA sequencing, which has enabled the sequencing of thousands to millions of DNA or RNA molecules simultaneously to detect mutations causing genetic disorders and even cancers. DNA sequencing provides the exact reason behind any disorder/disease.
In modern medicine, specific treatment is available for most of the diseases; this is specially true for cancer treatment. DNA sequencing can help to select the best therapy for a cancer patient. Therefore, this is the first most essential tool for Personalized Medicine.
Here in Suraksha, we perform molecular profiling with established guidelines of College of American Pathologists (CAP) and National Comprehensive Cancer Network (NCCN) which is a standard technique for classifying tumours.
Our Facility:
-
Comprehensive Cancer Hotspot Panel to detect NSCLC, Colorectal, Breast, Prostate, Head & Neck and many more cancers through screening of 50 oncogenes and almost 3000 actionable mutations
-
Screening & Comprehensive Panels for Breast Cancer which screen mutations in tumor suppressor genes BRCA1 and BRCA2
-
Non-invasive Prenatal Screening (NIPS) to detect abnormalities in developing fetus as early as 10th week of pregnancy with 99.9 % sensitivity and specificity and 0% risk of fetal injury.
-
Pre-implantation Genetic Screening (PGS) to select the best embryo for IVF implantation. Screening is performed on both frozen & fresh embryos.
Suraksha Diagnostic Limited
Plot No. DG- 12/1, Action Area 1D, Premises No.: 02-0327, New Town, Rajarhat, Kolkata – 700 156 West Bengal, India